NASDAQ:KRRO.O

Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come
····

Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come

Korro Bio shares closed at $11.61 Friday, up 3.66% and about 14% above the May 15 close, before U.S. markets shut for Memorial Day. The company named KRRO-111 as its new AATD drug candidate after an earlier setback, reporting over 90% RNA editing in mouse models. Korro ended Q1 with $157.1 million in cash and a narrower net loss. H.C. Wainwright cut its price target to $15 from $20.
May 23, 2026

Stock Market Today

  • NextDC Poised as Leading ASX Growth Stock Amid AI Infrastructure Surge
    May 27, 2026, 9:49 PM EDT. NextDC Ltd (ASX: NXT) emerges as a prominent ASX growth stock amid soaring demand for artificial intelligence (AI) infrastructure in Australia. The company operates 20 data centres nationwide, with plans for nine more and international expansion in Asia-Pacific. Its H1 FY26 results showed a 13% rise in net revenue, a 9% increase in underlying EBITDA, and 137% growth in contract utilisation. NextDC emphasises energy efficiency, integrating solar arrays and microgrids in its facilities. However, the stock trades at a high price-to-sales ratio of 24-25 times and reported a net loss of A$39.4 million in H1 FY26, reflecting significant cash burn typical of capital-intensive businesses. Execution and financial risks remain amid supply chain challenges and market conditions. Despite these risks, NextDC offers a strategic entry point into a booming AI and cloud infrastructure market.